Clinical Profiles and One-Year Outcome in Middle Eastern Pa-Tients With Atrial Fibrillation and Major Bleeding Events
Authors:
- Rashid IbdahRIRashid Ibdah
- Sukaina Ismael RawashdehSRSukaina Ismael Rawashdeh
- Ayman HammoudehAHAyman Hammoudeh
- Yahya BadainehYBYahya Badaineh
- Yousef KhaderYousef Khader
- Ramzi TabbalatRTRamzi Tabbalat
- Mustafa JammalMJMustafa Jammal
- Sadan AburummanSASadan Aburumman
- Ahmad Sadam ShannaqASAhmad Sadam Shannaq
- Imad A. AlhaddadIAImad A. Alhaddad
Preprint
- 13 March 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background. Oral anticoagulants (OACs) reduce stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) but increase the risk of major bleeding (MB). No study has addressed the incidence and outcomes of bleeding in AF patients in the Middle East (ME). The Jordan AF study evaluated clinical profiles and one-year outcomes of AF patients who sustained bleeding events. Methods. Patients in 29 hospitals and clinics (May 2019 - December 2020) were enrolled and followed up for one year. Demographics and one-year events were compared in patients with or without bleeding. Results. Of 2018 patients enrolled; 166 patients sustained MB or clinically relevant non-major (CRNM) bleeding (8.2 events per 100 patient-years), including 47 patients who had MB (2.3 events per 100 patient-years). Compared with 1852 (91.8%) patients who did not have bleeding, patients with MB were older and had a higher prevalence of hypertension, diabetes mellitus (DM), heart failure, and malignancy, More patients with MB than those with no bleeding were using OACs (93.6% vs. 78.9%, p=0.02). Patients with MB had significantly higher one-year rates of stroke/SE (23.4% vs. 3.6%, p<0.0001) and all-cause mortality (31.9% vs 11.6%, p=0.001). Independent predictors of MB were stroke/SE (OR 10.8, 95% CI 5.3-21.9, p<0.0001), malignancy (3.4, 1.3-8.5, p=0.01), use of OACs (4.4, 1.3-14.7, p=0.02) and DM (1.9, 1.0-3.5, p=0.04). Conclusions. MB and CRNM bleeding occurred in (≈8%) of patients with AF at one year. Patients with MB (≈2%) had worse baseline clinical profiles and one-year prognosis compared with those who did not have bleeding. Keywords: Atrial fibrillation; Major bleeding events; Clinically-relevant non-major bleeding; Oral anticoagulants; Middle Eastern population; Prognosis. Clinical studies registration: the study is registered on clinicaltrials.gov (unique identifier number NCT03917992).Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry programIJC Heart & Vasculature, 2021
- Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE‐AF)Clinical Cardiology, 2021
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial FibrillationJACC, 2019
- Incidence of thromboembolic and bleeding events in patients with newly diagnosed nonvalvular atrial fibrillation: An Asian multicenter retrospective cohort study in SingaporeClinical Cardiology, 2017
- Comparison of Bleeding Risk Scores in Patients With Nonvalvular Atrial Fibrillation Starting Direct Oral AnticoagulantsRevista Española de Cardiología (English Edition), 2017
- Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking RivaroxabanClinical Cardiology, 2015
- Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or WarfarinJACC, 2014
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial FibrillationJACC, 2007